US Payrolls Beat Expectations in April but Warning Signs Emerge OpenAI Moves to the Forefront of the AI IPO Race Getting to Public Markets First Is Very Important Chinese Investors Flock to Dividend Stocks Amid Market Uncertainty Kiplinger Highlights Key Earnings Reports for May 2529 Week US Advocacy Groups Call for Investigation into Roblox Over Child Safety and InGame Spending Concerns CPF LIFE vs SelfInvesting Retirement Decision Hinges on Financial Management in Old Age Educational Development Corporation Q1 2026 Earnings Reported Loss of 037 Per Share Stock Declines AESI Q1 2026 Earnings EPS Misses Estimates by Wide Margin AAR Corp AIR Q1 2026 Earnings Strong EPS Beat Driven by Aftermarket Demand and Operational Discipline SILO Q4 2023 Earnings EPS Misses Estimates as Biotech Firm Reports Wider Than Expected Loss LUNR Q1 2026 Earnings EPS Misses Expectations Amid PreRevenue Period Shares Surge 1572 ANIK Q1 2026 Earnings EPS Smashes Estimates by 265 but Stock Slips on Revenue Uncertainty aTyr Pharma ATYR Slides 27 Approaching Key Support at 048 Voyager Acquisition Corp VACH Drops 654 Support Levels Under Pressure Eaton Vance Enhanced Equity Income Fund EOI Holds Near Key Resistance After Modest Gain Silicon Laboratories Inc SLAB Edges Lower Consolidates Near Support at 207 PhenixFIN Notes PFXNZ Edge Higher Near Resistance Amid Subdued Trading US Consumer Prices Rise 38 in April Exceeding Expectations and Hitting Highest Since May 2023 BYRN Q1 2026 Earnings EPS Misses Estimates Stock Advances on Strategic Progress Dermata Therapeutics DRMA Shares Climb 385 as Stock Tests Key Resistance Levels BancFirst Corporation Q1 2026 Earnings EPS Beats Estimates Shares Edge Higher Identiv Inc INVE Q1 2026 Earnings EPS Falls Short of Estimates as Company Navigates Transition ALGT Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Discontinuation RYM Q3 2022 Earnings Deep Earnings Miss Amid Negative Surprise ST Bancorp STBA Q1 2026 Earnings EPS Beats Consensus by 672 Shares Edge Higher Kirby KEX Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline ONCY Q3 2025 Earnings Clinical Progress Overshadows WiderThanExpected Loss